Prodrugs of fused GABA analogs, pharmaceutical compositions...

Details Prodrugs of fused GABA analogs, pharmaceutical compositions... Prodrugs of fused GABA analogs, pharmaceutical compositions...

2006-06-13

2006-06-13

Dentz, Bernard (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

N-c doai

C514S354000, C514S452000, C514S461000, C546S322000, C549S372000, C549S450000, C560S028000

Reexamination Certificate

active

07060727

ABSTRACT:
The present invention relates generally to prodrugs of fused GABA analogs, pharmaceutical compositions of prodrugs of fused GABA analogs, methods of making prodrugs of fused GABA analogs and methods of using prodrugs of fused GABA analogs and pharmaceutical compositions of prodrugs of fused GABA analogs to treat or prevent various diseases.

REFERENCES:
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4024175 (1977-05-01), Satzinger et al.
patent: 4087544 (1978-05-01), Satzinger et al.
patent: 5084479 (1992-01-01), Woodruff
patent: 5112598 (1992-05-01), Biesalski
patent: 5556611 (1996-09-01), Biesalski
patent: 5563175 (1996-10-01), Silverman et al.
patent: 5698155 (1997-12-01), Grosswald et al.
patent: 6001876 (1999-12-01), Singh
patent: 6020370 (2000-02-01), Horwell et al.
patent: 6028214 (2000-02-01), Silverman et al.
patent: 6103932 (2000-08-01), Horwell et al.
patent: 6117906 (2000-09-01), Silverman et al.
patent: 6596900 (2003-07-01), Blakemore et al.
patent: WO 92/09560 (1992-06-01), None
patent: WO 93/23383 (1993-11-01), None
patent: WO 97/29101 (1997-08-01), None
patent: WO 97/33858 (1997-09-01), None
patent: WO 97/33859 (1997-09-01), None
patent: WO 98/17627 (1998-04-01), None
patent: WO 99/08671 (1999-02-01), None
patent: WO 99/21824 (1999-05-01), None
patent: WO 99/31057 (1999-06-01), None
patent: WO 99/31074 (1999-06-01), None
patent: WO 99/31074 (1999-06-01), None
patent: WO 99/31075 (1999-06-01), None
patent: WO 99/37296 (1999-07-01), None
patent: WO 99/61424 (1999-12-01), None
patent: WO 00/23067 (2000-04-01), None
patent: WO 00/31020 (2000-06-01), None
patent: WO 00/50027 (2000-08-01), None
patent: WO 01/28978 (2001-04-01), None
patent: WO 02/00209 (2002-01-01), None
patent: WO 02/00209 (2002-01-01), None
patent: WO 00/15611 (2002-03-01), None
patent: WO 02/085839 (2002-10-01), None
patent: WO 02/090318 (2002-11-01), None
U.S. Appl. No. 10/171,485, Gallop et al.
U.S. Appl. No. 10/170,127, Cundy et al.
U.S. Appl. No. 10/167,797, Gallop et al.
Alderman, “A Review of Cellulose Ethers in Hydrophilic Matrices or Oral controlled-Release Dosage Forms,”Int. J. Pharm. Tech.&Prod. Mfr.1984, 5(3) 1-9.
Bamba et al., “Release Mechanisms in Gelforming Sustained Release Preparation,”Int. J. Pharm. 1979, 2, 307.
Bryans et al., “3-Substituted GABA Analogs with Central Nervous System Activity: A Review,”Med. Res. Rev. 1999, 19, 149-177.
During et al., “Controlled release of dopamine from a polymeric brain implant: in vivo characterization,” 1989,Ann. Neurol. 25:351.
Goodson, “Medical Applications of Controlled Release,” vol. 2, pp. 115-138 (1984).
Howard et al., “Intercerebral Drug Delivery in Rats with Lesion-Induced Memory Deficits,” 1989,J. Neurosurg. 71:105-112.
Jezyk et al., “Transport of Pregabalin in Rat Intestine and Caco-2 Monolayers,”Pharm. Res. 1999, 16, 519-526.
Langer et al., “Chemical and Physical Structure of Polymers as Carriers for Controlled Release of Bioactive Agents: A Review,”J Macromol. Sci. Rev. Macromol. Chem. 1983, 23:61.
Langer, “New Method of Drug Delivery,” 1990,Science249:1527-1533.
Levy et al., “Inhibition of Calcification of Bioprosthetic Heart Valves by Local Controlled-Release Diphosphonate,”Science1985 228: 190-192.
Magnus, “Nonepileptic Uses of Gabapentin,”Epilepsia, (40) (Suppl. 6): S66-S72 (1999).
Saudek et al., “A Preliminary Trial of the Programmable Implantable Medication System for Insulin Delivery,”N. Engl. J. Med., 1989, 321: 574.
Sefton, “Implantable Pumps,”CRC Crit Ref Biomed. Eng. 1987, 14:201.
Verma et al., “Osmotically Controlled Oral Drug Delivery,”Drug Dev. Ind. Pharm., 2000, 26:695-708.

Affiliated with

Also associated with

Rating

Prodrugs of fused GABA analogs, pharmaceutical compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prodrugs of fused GABA analogs, pharmaceutical compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prodrugs of fused GABA analogs, pharmaceutical compositions... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3641943